Panagora Asset Management’s GSK GSK Stock Holding History

Panagora Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Buy	+6,955	New	+$368K	﹤0.01%	976
2022 Q3	–	Sell	-8,574	Closed	-$467K	–	1470
2022 Q2	$467K	Hold	8,574	–	–	﹤0.01%	1179
2022 Q1	$467K	Buy	+8,574	New	+$466K	﹤0.01%	1234
2014 Q3	–	Sell	-528	Closed	-$35K	–	2305
2014 Q2	$35K	Buy	+528	New	+$35.7K	﹤0.01%	2160

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Panagora Asset Management's GSK Position: Q2 2026 in Review

Panagora Asset Management opened a new position in GSK (GSK) in Q2 2026: 6,955 shares worth $365K. The stake represents ﹤0.01% of the portfolio and ranks #976 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in GSK as recently as Q2 2022.

Panagora Asset Management first reported a position in GSK in Q2 2014 and has held it in 4 quarters since. The position peaked at $467K in Q2 2022. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Panagora Asset Management held 6,955 shares of GSK worth $365K as of Q2 2026.
GSK was a new Panagora Asset Management position in Q2 2026.
GSK made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #976 holding.
Panagora Asset Management first reported a position in GSK in Q2 2014 and has held it in 4 quarters since.
Panagora Asset Management's GSK position peaked at $467K in Q2 2022.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.